Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Medexus Pharmaceuticals Inc

Medexus Schedules Third Quarter Fiscal 2021 Conference Call
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Announces Closing of $32.5 Million Public Offering, Including Exercise in Full of Over-Allotment Option
Tickers MDP
From GlobeNewswire News Releases
Medexus to Present at the Winter Wonderland Conference- Best Ideas from the Buy-Side
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Announces Upsize to Previously Announced Bought Deal Public Offering
Tickers MDP
From GlobeNewswire News Releases
Medexus Announces $20 Million Bought Deal Public Offering of Units
Tickers MDP
From GlobeNewswire News Releases
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA®
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Submits Application to List on the Nasdaq
Management to host investor update webinar on January 25th at 2pm Eastern 
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Engages Independent Trading Group for Market Making Services
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Announces Annual Equity Incentive Grants to Non-Executive Directors
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Enters into Exclusive License to Register and Commercialize Triamcinolone Hexacetonide (TH) in the United States with Ethypharm
Drug shortage in the United States driving need for Triamcinolone Hexacetonide 
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus to Present at The 13th Annual LD Micro Main Event Conference on December 15th
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Pharmaceuticals Reports Operating and Financial Results for the Three- and Six-Month Periods Ending September 30, 2020
Management to host conference call at 8:00 AM Eastern Time on Tuesday, November 17th, 2020 
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients
Tickers APVO MDP
From GlobeNewswire News Releases
Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2021 Conference Call
Conference call to be held at 8:00 AM Eastern Time on Tuesday, November 17th, 2020 
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Appoints Michael Pine as Senior Vice President of Business Development and Strategy
Tickers MDP
From GlobeNewswire News Releases
Medexus Engages Adelaide Capital for Investor Relations Services and Reports Annual Meeting Results
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Reports Health Canada Approval of Gleolan® (5-ALA) for Use in Guided Surgical Resection of High-Grade Gliomas
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Announces Move to a Virtual Meeting for 2020 AGM and Equity Incentive Grants
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus Reports Triamcinolone Hexacetonide Injectable Suspension Approved for Inclusion on Quebec’s RAMQ List of Medications (Basic Plan and Institutions)
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Announces New U.S. Ticker “MEDXF” on the OTCQX
Medexus will continue to trade on the TSX Venture under ticker “MDP” 
Tickers MDP MEDXF
From GlobeNewswire News Releases
Medexus Pharmaceuticals Reports Record Revenue of $27.5 Million and $5.0 Million of Adjusted EBITDA* for the First Quarter of Fiscal 2021
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12th
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus Pharmaceuticals Schedules First Quarter Fiscal 2021 Conference Call
Conference call to be held at 8:00 AM Eastern Time on Wednesday, August 12, 2020 
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus Reports Triamcinolone Hexacetonide Injectable Suspension Approved for Inclusion on Federal/Provincial/Territorial Public Drug Plan Formularies
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus Pharmaceuticals Reports Record Revenue of $25.6 Million and $4.2 Million of Adjusted EBITDA* for the Fourth Quarter of Fiscal 2020
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus Pharmaceuticals Schedules Fiscal Year 2020 Conference Call
Conference call to be held at 8:00 AM Eastern Time on Tuesday, June 23, 2020 
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus to Present at the Virtual Summer Summit on June 10th
Tickers MDP PDDPF
From GlobeNewswire News Releases
Medexus Provides an Update on the IXINITY® Acquisition and its Overall Business in the COVID-19 Environment
Tickers MDP PDDPF
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.